Skip to main content
. 2017 Jan 23;12(1):e0170362. doi: 10.1371/journal.pone.0170362

Fig 3. Cumulative rates of a complete virological response (CVR) at week 96 according to subgroup.

Fig 3

(A) Comparison of CVR between NA-naïve and LAM-R patients, (91.5% vs. 88.4%, P = 0.677) and between NA-naïve patients and the suboptimal response group (91.5% vs. 83.3%, P = 0.761). (B) Comparison of CVR between NA-naïve and ADV-R patients, (91.5% vs. 75.0%, P = 0.023) and between NA-naïve patients and the MDR group (91.5% vs. 75.5%, P = 0.256). NA, nucleos(t)ide analogue; LAM, lamivudine; R, resistant; ADV, adefovir; MDR, multidrug-resistant.